Independent Wealth Network’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$537K Sell
2,132
-126
-6% -$27.1K 0.14% 171
2026
Q1
$491K Sell
2,258
-49
-2% -$10.9K 0.15% 167
2025
Q4
$527K Buy
2,307
+92
+4% +$21K 0.16% 143
2025
Q3
$513K Buy
2,215
+7
+0.3% +$1.43K 0.16% 145
2025
Q2
$410K Buy
2,208
+105
+5% +$19.5K 0.15% 157
2025
Q1
$441K Sell
2,103
-717
-25% -$139K 0.18% 140
2024
Q4
$501K Sell
2,820
-202
-7% -$37.1K 0.2% 126
2024
Q3
$597K Buy
3,022
+787
+35% +$147K 0.26% 101
2024
Q2
$383K Buy
2,235
+200
+10% +$33.1K 0.18% 137
2024
Q1
$371K Sell
2,035
-199
-9% -$34.3K 0.17% 143
2023
Q4
$346K Sell
2,234
-89
-4% -$13K 0.18% 135
2023
Q3
$346K Sell
2,323
-26
-1% -$3.82K 0.21% 120
2023
Q2
$316K Sell
2,349
-568
-19% -$83.3K 0.19% 140
2023
Q1
$465K Buy
2,917
+388
+15% +$59.3K 0.3% 81
2022
Q4
$409K Sell
2,529
-42
-2% -$6.44K 0.28% 90
2022
Q3
$345K Buy
2,571
+492
+24% +$70.6K 0.27% 100
2022
Q2
$318K Sell
2,079
-227
-10% -$34.7K 0.23% 118
2022
Q1
$374K Buy
+2,306
New +$335K 0.24% 116

Other funds holding ABBV

Independent Wealth Network's ABBV Position: Q2 2026 in Review

Independent Wealth Network reduced its AbbVie (ABBV) stake by 5.6% in Q2 2026, selling an estimated $27.1K and leaving 2,132 shares worth $537K. The position accounts for 0.14% of the portfolio, ranked #171.

Independent Wealth Network first reported a position in ABBV in Q1 2022 and has held it in 18 quarters since. The position peaked at $597K in Q3 2024. 1,316 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Independent Wealth Network held 2,132 shares of AbbVie worth $537K as of Q2 2026.
  • Independent Wealth Network sold 126 AbbVie shares in Q2 2026, an estimated $27.1K.
  • AbbVie made up 0.14% of Independent Wealth Network's portfolio in Q2 2026, its #171 holding.
  • Independent Wealth Network first reported a position in AbbVie in Q1 2022 and has held it in 18 quarters since.
  • Independent Wealth Network's AbbVie position peaked at $597K in Q3 2024.
  • 1,316 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Independent Wealth Network's 13F filing for Q2 2026, filed 20 Jul 2026.